ZNF271P

Across TCGA pan-cancer cohorts, ZNF271P Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ZNF271P data layer compared with 23 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ZNF271P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF271P expression acts as an unfavorable survival marker, although some lineages such as COAD show a favorable association.

BLCA, UCEC, and LUAD are the cancer types where ZNF271P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	IV	0.089	0.599	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUAD	DFS	Median	II,III,IV	0.098	0.651	.001	3	view →
LIHC	OS	Median	All	0.188	0.669	.041	3	view →
COAD	DFS	Median	All	1.000	0.465	.036	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ZNF271P–BLCA (OS)

Open the BLCA breakdown →